Neurodegenrative changes in retina of rats with chronic epileptic syndrome under conditions of treatment with niacin-oxy-ethylidene-phosphonate germanate (MIGU-4)

Authors

DOI:

https://doi.org/10.31288/oftalmolzh202322630

Keywords:

pentylenetetrazol kindling, chronic epileptic syndrome, retinopathy, niacin-oxy-ethylidene-phosphonate germinate (MIGU-4), neuroprotection

Abstract

Background: Epilepsy is accompanied by neurodegenerative changes, particularly those in the retina. Elucidation of the mechanisms of retinal alterations in a model of epileptic syndrome may allow for the development of new approaches to pharmacological vision correction.

Purpose: To assess the morphological characteristics of the retina, particularly treated with niacin oxy-ethylidene phosphonate germinate (MIGU-4), in the pentylenetetrazole (PTZ)-induced kindling model of chronic epileptic syndrome.

Material and Methods: PTZ was administered in Wistar male rats intraperitoneally (i.p.) at a daily dose of 35.0 mg/kg for 21 days. Rats with fully-developed generalized seizures were treated with MIGU-4 ip at a daily dose of 5.0 mg/kg or 25.0 mg/kg for 28 days. Thereafter, the animals were euthanized, their globes were enucleated, and retinal sections were prepared and stained with hematoxylin and eosin for morphological examination.

Results: Cell density in the retinal ganglion cell layer was 2.14 times lower, and in the inner nuclear layer and outer nuclear layer, 41.0% and 19.0%, respectively, lower for the rats with fully developed kindled seizures than for controls (р < 0.05). In the presence of treatment with MIGU-4 ip at a daily dose of 25.0 mg/kg, cell density in the retinal ganglion cell layer and in the inner nuclear layer was 38% and 30.5%, respectively, higher than for controls (р < 0.05). There was no significant difference in the cell density in the outer nuclear layer between rats treated with MIGU-4 ip at a daily dose of 5 mg/kg or 25.0 mg/kg and controls (р > 0.05).

Conclusion: The PTZ-induced kindling model of chronic epileptic syndrome is accompanied by degenerative changes in the eye. A course of treatment with MIGU-4 causes neuroptotective effects in a model of PTZ-induced retinopathy.

Author Biography

N. Al-Nadawi, Odesa National Medical University

Assistant

References

Волошенков ДБ, Кащенко ОА, Годован ВВ, Шандра ОА. Вплив похідних дифосфонату германію з нікотинамідом, нікотиновою кислотою та магнієм на ригидність м'язів, тремор і салівацію у щурів та мишей. Одеський мед. журнал. 2005;4 (90):21-4.

Годован ВВ, Кресюн ВЙ. Стан системи антиоксидантного захисту клітини при галактозаміновому гепатиті та застосуванні похідних оксіетилідендифосфонатогерманатів (Повідомлення 1). Одеський мед. журнал. 2007а;4 (102):36-41.

Годован ВВ, Кресюн ВЙ. Стан системи антиоксидантного захисту клітини при галактозаміновому гепатиті та застосуванні похідних оксіетилідендифосфонатогерманатів (Повідомлення 2). Одеський мед. журнал. 2007б;5(103):С. 5-10.

Кресюн НВ. Нейродегенеративні зміни сітківки ока щурів зі стрептозотоциновим діабетом за різних умов експериментального лікування. Запорізький мед. журнал. 2014;4:21-5.

Wada Т, Hanyu Т, Nozaki K, et al. Antioxidant activity of Ge-132, a synthetic organic germanium, on cultured mammalian cells. Biol. Pharm. Bull. 2018;41(5)749-53. https://doi.org/10.1248/bpb.b17-00949

Devinsky О, Vezzani А, O'Brienetal Т. Epilepsy. NatRevDisPrimers. 2018;4. AreticleID 18024. https://doi.org/10.1038/nrdp.2018.24

Cho JM, Chae J, Jeong SR, et al. Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights. PLoS One. 2020;15(10). Article ID e0240358. https://doi.org/10.1371/journal.pone.0240358

Ahl M, Avdic U, Skoug C, et al. Immune response in the eye following epileptic seizures. Neuroinflamm. 2016;13:155. https://doi.org/10.1186/s12974-016-0618-3

Jaiswal G, Kumar P. Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS. Behav. Brain Res. 2022;419. https://doi.org/10.1016/j.bbr.2021.113699

Kresyun NV, Godlevskii LS. Superoxide dismutase and catalase activities in the retina during experimental diabetes and electric stimulation of the paleocerebellar cortex. Bull. Exp. Biol. Med. 2014;158(2):206-8. https://doi.org/10.1007/s10517-014-2723-6

Bayraktar BN, Titiz AP, Bilen S, et al. Optical coherence tomography and neurodegeneration in epilepsy. Eur. J. Ophthalmol. 2021;31(1);252-7. https://doi.org/10.1177/1120672119881982

Takeda T, Doiyama S, Azumiet J, et al. Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblasts. Sci Rep. 2019;9. Article ID 13637. https://doi.org/10.1038/s41598-019-49883-7

El-Megiri N, Mostafa YM, Ahmed А, et al. Pioglitazone ameliorates hippocampal neurodegeneration, disturbances in glucose metabolism and AKT/mTOR signaling pathways in pentyelenetetrazole-kindled mice. Pharmaceuticals. 2022;5:1113. https://doi.org/10.3390/ph15091113

Hazirolan D, Duman M, Guler SK, et al. Retinal ganglion cell complex and visual evoked potentials in levetiracetam treatment. Cutan. Ocul. Toxicol. 2020;39(3);237-43. https://doi.org/10.1080/15569527.2020.1778016

Shandra AA, Godlevsky LS. Antiepileptic effects of cerebellar nucleus dentatus electrical stimulation under different conditions of brain epileptisation. Indian J Exp Biol. 1990;28(2):158-61.

Published

2023-04-25

How to Cite

1.
Al-Nadawi N, Kresyun V. Neurodegenrative changes in retina of rats with chronic epileptic syndrome under conditions of treatment with niacin-oxy-ethylidene-phosphonate germanate (MIGU-4). J.ophthalmol. (Ukraine) [Internet]. 2023 Apr. 25 [cited 2024 May 29];(2):26-30. Available from: https://ua.ozhurnal.com/index.php/files/article/view/23

Issue

Section

Experimental Studies